Arabic Arabic English English French French German German

This proposes the possibility of Entelon as an effective adjuvant for treating triple-negative breast cancer.


Molecules. 2021 Jun 15 ;26(12). Epub 2021 Jun 15. PMID: 34203721

Abstract Title: 

Entelon(Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells.


Interleukin-1 (IL1) is a proinflammatory cytokine and promotes cancer cell proliferation and invasiveness in a diversity of cancers, such as breast and colon cancer. Here, we focused on the pharmacological effect of Entelon(ETL) on the tumorigenesis of triple-negative breast cancer (TNBC) cells by IL1-alpha (IL1A). IL1A enhanced the cell growth and invasiveness of TNBC cells. We observed that abnormal IL1A induction is related with the poor prognosis of TNBC patients. IL1A also increased a variety of chemokines such as CCL2 and IL8. Interestingly, IL1A expression was reduced by the ETL treatment. Here, we found that ETL significantly decreased the MEK/ERK signaling pathway in TNBC cells. IL1A expression was reduced by UO126. Lastly, we studied the effect of ETL on the metastatic potential of TNBC cells. Our results showed that ETL significantly reduced the lung metastasis of TNBC cells. Our results showed that IL1A expression was regulated by the MEK/ERK- and PI3K/AKT-dependent pathway. Taken together, ETL inhibited the MEK/ERK and PI3K/AKT signaling pathway and suppressing the lung metastasis of TNBC cells through downregulation of IL1A. Therefore, we propose the possibility of ETL as an effective adjuvant for treating TNBC.

read more

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Central administration of ampelopsin A isolated from Vitis vinifera ameliorates cognitive and memory function.

Next Post

Histological evidence of wound healing improvement in rats treated with oral administration of hydroalcoholic extract of Vitis labrusca.

Related Posts